ESR1 and triple-negative breast carcinoma: A subset of advanced breast cancers are diagnosed as triple-negative breast cancer (TNBC), lacking expression of the estrogen receptor (ER), progesterone receptor (PR), and the Her2 tyrosine kinase receptor (1, 8).